RNA-Seq Comparative Analysis of Peking Ducks Spleen Gene
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Method for Detecting Antibody Against BDV (Borna Disease Virus) for Detecting a BDV Infection
Europäisches Patentamt *EP001460426A1* (19) European Patent Office Office européen des brevets (11) EP 1 460 426 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.7: G01N 33/569 22.09.2004 Bulletin 2004/39 (21) Application number: 04006699.5 (22) Date of filing: 19.03.2004 (84) Designated Contracting States: (72) Inventors: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR • Yamaguchi, Kazunari, HU IE IT LI LU MC NL PL PT RO SE SI SK TR Nat.Inst.Infectious Diseases Designated Extension States: Musashimurayama-shi, Tokyo 208-0011 (JP) AL LT LV MK • Horii, Yoichiro, Faculty of Agriculture Miyazaki-shi, Miyazaki 889-2192 (JP) (30) Priority: 20.03.2003 JP 2003078898 • Takahama, Yoichi, Sysmex Corporation 26.03.2003 JP 2003086490 Kobe-shi, Hyogo 651-0073 (JP) 26.03.2003 JP 2003086491 • Nagai, Shinya, Sysmex Corporation Kobe-shi, Hyogo 651-0073 (JP) (71) Applicant: Sysmex Corporation Kobe-shi, Hyogo 651-0073 (JP) (74) Representative: HOFFMANN - EITLE Patent- und Rechtsanwälte Arabellastrasse 4 81925 München (DE) (54) Method for detecting antibody against BDV (Borna disease virus) for detecting a BDV infection (57) With respect to immunoglobulins that are performing the examination of an antibody to Borna dis- raised against an exogenous antigen, when the class ease virus (may be referred to as "BDV") as an example switching from IgM to IgG necessitates a long period of of such an exogenous antigen in a more accurate man- time, detect of IgM antibody alone, or concurrent detect ner, and a method for detecting anti-BDV antibody in of the IgM antibodies and IgG antibodies to the exoge- which such a polypeptide is used are provided. -
Novel Therapeutics for Epstein–Barr Virus
molecules Review Novel Therapeutics for Epstein–Barr Virus Graciela Andrei *, Erika Trompet and Robert Snoeck Laboratory of Virology and Chemotherapy, Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium; [email protected] (E.T.); [email protected] (R.S.) * Correspondence: [email protected]; Tel.: +32-16-321-915 Academic Editor: Stefano Aquaro Received: 15 February 2019; Accepted: 4 March 2019; Published: 12 March 2019 Abstract: Epstein–Barr virus (EBV) is a human γ-herpesvirus that infects up to 95% of the adult population. Primary EBV infection usually occurs during childhood and is generally asymptomatic, though the virus can cause infectious mononucleosis in 35–50% of the cases when infection occurs later in life. EBV infects mainly B-cells and epithelial cells, establishing latency in resting memory B-cells and possibly also in epithelial cells. EBV is recognized as an oncogenic virus but in immunocompetent hosts, EBV reactivation is controlled by the immune response preventing transformation in vivo. Under immunosuppression, regardless of the cause, the immune system can lose control of EBV replication, which may result in the appearance of neoplasms. The primary malignancies related to EBV are B-cell lymphomas and nasopharyngeal carcinoma, which reflects the primary cell targets of viral infection in vivo. Although a number of antivirals were proven to inhibit EBV replication in vitro, they had limited success in the clinic and to date no antiviral drug has been approved for the treatment of EBV infections. We review here the antiviral drugs that have been evaluated in the clinic to treat EBV infections and discuss novel molecules with anti-EBV activity under investigation as well as new strategies to treat EBV-related diseases. -
Where Do We Stand After Decades of Studying Human Cytomegalovirus?
microorganisms Review Where do we Stand after Decades of Studying Human Cytomegalovirus? 1, 2, 1 1 Francesca Gugliesi y, Alessandra Coscia y, Gloria Griffante , Ganna Galitska , Selina Pasquero 1, Camilla Albano 1 and Matteo Biolatti 1,* 1 Laboratory of Pathogenesis of Viral Infections, Department of Public Health and Pediatric Sciences, University of Turin, 10126 Turin, Italy; [email protected] (F.G.); gloria.griff[email protected] (G.G.); [email protected] (G.G.); [email protected] (S.P.); [email protected] (C.A.) 2 Complex Structure Neonatology Unit, Department of Public Health and Pediatric Sciences, University of Turin, 10126 Turin, Italy; [email protected] * Correspondence: [email protected] These authors contributed equally to this work. y Received: 19 March 2020; Accepted: 5 May 2020; Published: 8 May 2020 Abstract: Human cytomegalovirus (HCMV), a linear double-stranded DNA betaherpesvirus belonging to the family of Herpesviridae, is characterized by widespread seroprevalence, ranging between 56% and 94%, strictly dependent on the socioeconomic background of the country being considered. Typically, HCMV causes asymptomatic infection in the immunocompetent population, while in immunocompromised individuals or when transmitted vertically from the mother to the fetus it leads to systemic disease with severe complications and high mortality rate. Following primary infection, HCMV establishes a state of latency primarily in myeloid cells, from which it can be reactivated by various inflammatory stimuli. Several studies have shown that HCMV, despite being a DNA virus, is highly prone to genetic variability that strongly influences its replication and dissemination rates as well as cellular tropism. In this scenario, the few currently available drugs for the treatment of HCMV infections are characterized by high toxicity, poor oral bioavailability, and emerging resistance. -
Duck Viral Enteritis (Duck Plague) in North American Waterfowl
DUCK VIRAL ENTERITIS (DUCK PLAGUE) IN NORTH AMERICAN WATERFOWL By Louis N. Locke,l Louis Leibovitz,2 Carlton M. Herman, 1 and John W. Walker3 Duck Viral Enteritis (DVE) was first recognized in North America in January 1967, when an outbreak occured in a commercial flock of white Pekin ducks in Suffolk County, Long Island, New York (Leibovitz & Hwang, 1968b). Originally described as a disease of domestic ducks in the Netherlands, DVE has since been reported from I ndia and Belgium. It is also believed to have occurred in China and France (Jansen, 1968). This paper briefly reviews the status of DVE among wild waterfowl in North America and describes some of the characteristic lesions associated with this disease. The paper also mentions some of the work which has been undertaken to learn more about the status of DVE in North America. DVE in wild waterfowl was diagnosed on February 1, 1967, from a dead mute swan (Cygnus a/or) submitted to the Long Island Duck Research Laboratory (Leibovitz & Hwang, 1968a). This swan had been found dead the previous day on a lagoon which bordered the Baker duck farms where the first outbreak occurred in Pekins in Suffolk County, Long Island, New York. Additional cases of Duck Plague on Long Island have involved the mallard (Anas p/atyrhynchas), black duck (A. rubripes), Canada goose (Branta canadensis), greater scaup (Aythya marital, and bufflehead (Bucepha/a albea/a) (Leibovitz, 1968). Two outbreaks have occurred in muscovy ducks (Cairina Moschata), one of these in Suffolk County, and the other near Horseheads, Chemung County, New York (upstate), approximately 200 miles from the Long Island outbreaks. -
Risk Groups: Viruses (C) 1988, American Biological Safety Association
Rev.: 1.0 Risk Groups: Viruses (c) 1988, American Biological Safety Association BL RG RG RG RG RG LCDC-96 Belgium-97 ID Name Viral group Comments BMBL-93 CDC NIH rDNA-97 EU-96 Australia-95 HP AP (Canada) Annex VIII Flaviviridae/ Flavivirus (Grp 2 Absettarov, TBE 4 4 4 implied 3 3 4 + B Arbovirus) Acute haemorrhagic taxonomy 2, Enterovirus 3 conjunctivitis virus Picornaviridae 2 + different 70 (AHC) Adenovirus 4 Adenoviridae 2 2 (incl animal) 2 2 + (human,all types) 5 Aino X-Arboviruses 6 Akabane X-Arboviruses 7 Alastrim Poxviridae Restricted 4 4, Foot-and- 8 Aphthovirus Picornaviridae 2 mouth disease + viruses 9 Araguari X-Arboviruses (feces of children 10 Astroviridae Astroviridae 2 2 + + and lambs) Avian leukosis virus 11 Viral vector/Animal retrovirus 1 3 (wild strain) + (ALV) 3, (Rous 12 Avian sarcoma virus Viral vector/Animal retrovirus 1 sarcoma virus, + RSV wild strain) 13 Baculovirus Viral vector/Animal virus 1 + Togaviridae/ Alphavirus (Grp 14 Barmah Forest 2 A Arbovirus) 15 Batama X-Arboviruses 16 Batken X-Arboviruses Togaviridae/ Alphavirus (Grp 17 Bebaru virus 2 2 2 2 + A Arbovirus) 18 Bhanja X-Arboviruses 19 Bimbo X-Arboviruses Blood-borne hepatitis 20 viruses not yet Unclassified viruses 2 implied 2 implied 3 (**)D 3 + identified 21 Bluetongue X-Arboviruses 22 Bobaya X-Arboviruses 23 Bobia X-Arboviruses Bovine 24 immunodeficiency Viral vector/Animal retrovirus 3 (wild strain) + virus (BIV) 3, Bovine Bovine leukemia 25 Viral vector/Animal retrovirus 1 lymphosarcoma + virus (BLV) virus wild strain Bovine papilloma Papovavirus/ -
Herpes B Virus: Implications in Lab Workers, Travelers, and Pet Owners
Herpes B Virus: Implications in Lab Workers, Travelers, and Pet Owners Presenter: Kevin Johnson DO, MPH Chief Resident Harvard OEMR Discussant: Thomas Winters, MD, FACOEM Chief Medical Officer and Principal Partner OEHN Objectives 1. Discuss how Herpes B infection is transmitted 2. List symptoms of Herpes B infection in humans 3. Describe vaccination and treatment options for Herpes B. The Case of a Lab Worker • S: . 53 y/o clinician/researcher at a local lab went to MGH with fever, HA, and rigors 3/27/12. Notes being scratched by a research monkey (Macaque sp) 9 days prior on dorsum of L hand. Washed the wound for few minutes but did not report the injury. Negative for neck pain, or difficulty with concentration. • O: . PE: Scar longitudinal between 3rd and 4th MC L hand 3 cm. Negative for vesicular lesions, erythema, signs of infection, or rashes • Labs: . LP's performed weekly with Herpes B negative on PCR . Elevated WBC’s seen on CBC • Imaging: . 2 MRI’s were normal On week 3 LP again performed with PCR of CSF positive for Herpes B and serology with Ab (+) A: Diagnosed with Meningoencephelitis 2/2 to Herpes B infection Background (History) First documented case of B-virus infection in 1932 when a researcher was bitten on the hand by an apparently healthy rhesus macaque and died of progressive encephalomyelitis 15 days later. Background • Transmission via contact with oral-secretions . Direct (bite, scratch, contact with body fluid or tissue) . Indirect (contaminated fomite e.g., needle puncture or cage scratch) . Human-to-human transmission has been documented in one case Macaque Attack!!!! What About Travelers? • B virus prevalent in macaques native to SE Asia. -
Cross-Species Antiviral Activity of Goose Interferons Against Duck
viruses Article Cross-Species Antiviral Activity of Goose Interferons against Duck Plague Virus Is Related to Its Positive Self-Feedback Regulation and Subsequent Interferon Stimulated Genes Induction Hao Zhou 1,†, Shun Chen 1,2,3,*,†, Qin Zhou 1, Yunan Wei 1, Mingshu Wang 1,2,3, Renyong Jia 1,2,3, Dekang Zhu 2,3, Mafeng Liu 1, Fei Liu 3, Qiao Yang 1,2,3, Ying Wu 1,2,3, Kunfeng Sun 1,2,3, Xiaoyue Chen 2,3 and Anchun Cheng 1,2,3,* 1 Institute of Preventive Veterinary Medicine, Sichuan Agricultural University, No. 211 Huimin Road, Wenjiang District, Chengdu 611130, China; [email protected] (H.Z.); [email protected] (Q.Z.); [email protected] (Y.W.); [email protected] (M.W.); [email protected] (R.J.); [email protected] (M.L.); [email protected] (Q.Y.); [email protected] (Y.W.); [email protected] (K.S.) 2 Avian Disease Research Center, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, China; [email protected] (D.Z.); [email protected] (X.C.) 3 Key Laboratory of Animal Disease and Human Health of Sichuan Province, Sichuan Agricultural University, Chengdu 611130, China; [email protected] * Correspondence: [email protected] (S.C.); [email protected] (A.C.); Tel.: +86-028-86291482 † These authors contributed equally to this work. Academic Editor: Curt Hagedorn Received: 23 May 2016; Accepted: 12 July 2016; Published: 18 July 2016 Abstract: Interferons are a group of antiviral cytokines acting as the first line of defense in the antiviral immunity. Here, we describe the antiviral activity of goose type I interferon (IFNα) and type II interferon (IFNγ) against duck plague virus (DPV). -
Ev20n1p53.Pdf (663.1Kb)
SEROLOGIC SCREENING FOR CYTOMEGALOVIRUS, RUBELLA VIRUS, HERPESSIMPLEX VIRUS, HEPATITIS B VIRUS, AND Z-DXOl?~snIlA GONDII IN TWO URBAN POPULATIONS OF PREGNANT WOMEN IN CHILE1 Pablo Vzlzl;2 Jorge Toves-Pereyra, 3 Sergio Stagno, 4 Francisco Gonzhfez,’ Enrique Donoso, G Chades A. Allford, 7 Zimara Hirsch, 8 and Luk Rodtiguezg I NTRODUCTION these agents represent naturally acquired infections. There are only a few reports Although the prevalence of concerning the epidemiology of congeni- congenital and perinatal infections is tal and perinatal infections in Chile (l- high, however, it is.unclear whether their $&In general, these reports show that incidence during the childbearing years the prevalences of infection with most of (and hence their potential to cause fetal the causative agents are high and that disease) is different from that observed in most infections are acquired at an early communities such as those in developed age. Since vaccinations against cytomeg- countries where lower prevalences are the alovirus (CMV), herpes simplex virus rule. Therefore, in order to help assess (HSV), and Toxopl’asma gondii have not the importance of CMV, HSV, rubella, yet been introduced, high prevalences of HBV, and ToxopLasmagondii as causesof z 2 < ’ This article is also being published in Spanish in the 4 Department of Pediatrics, University of Alabama. Bir- 2 BoLefin de /a Oficina Sanitankz Panameticana, 99(5), mingham. Alabama, United States. % 1985. The work reported here was supported by Grant s Division of Obstetrics and Gynecology, Dr. Sotero de1 x ‘4 LHZ503Q from the Pan American Health Organita- Rio Hospital, Puente Alto, Chile. u 6 Department of Obstetrics and Gynecology. -
Viral Hepatitis B: Introduction
Viral Hepatitis B: Introduction “Viral hepatitis," refers to infections that affect the liver and are caused by viruses. It is a major public health issue in the United States and worldwide. Not only does viral hepatitis carry a high morbidity, but it also stresses medical resources and can have severe economic consequences. The majority of all viral hepatitis cases are preventable. Viral hepatitis includes five distinct disease entities, which are caused by at least five different viruses. Hepatitis A and hepatitis B (infectious and serum hepatitis, respectively) are considered separate diseases and both can be diagnosed by a specific serologic test. Hepatitis C and E comprise a third category, each a distinct type, with Hepatitis C parenterally transmitted, and hepatitis E enterically transmitted. Hepatitis D, or delta hepatitis, is another distinct virus that is dependent upon hepatitis B infection. This form of hepatitis may occur as a super-infectionin a hepatitis B carrier or as a co-infection in an individual with acute hepatitis B. Hepatitis viruses most often found in the United States include A, B, C, and D. Because fatality from hepatitis is relatively low, mortality figures are a poor indicator of the actual incidence of these diseases. The Centers for Disease Control and Prevention estimated that approximately 400,000–600,000 people were infected with viral hepatitis during the decade of the 1990s. Hepatitis plagued mankind as early as the fifth century BC. It was referenced in early biblical literature and described as occurring in outbreaks, especially during times of war. Toward the end of the nineteenth century, hepatitis was thought to occur as a result of infection of the hepatic parenchyma. -
Identification and Characterization of the Duck Enteritis Virus (DEV) US2 Gene
Identification and characterization of the duck enteritis virus (DEV) US2 gene J. Gao1,2,3, A.C. Cheng1,2,3, M.S. Wang1,2,3, R.Y. Jia1,2,3, D.K. Zhu2,3, S. Chen1,2,3, M.F. Liu1,2,3, F. Liu3, Q. Yang1,2,3, K.F. Sun1,2,3 and X.Y. Chen2,3 1Institute of Preventive Veterinary Medicine, Sichuan Agricultural University, Wenjiang, Chengdu, Sichuan, China 2Avian Disease Research Center, College of Veterinary Medicine of Sichuan Agricultural University, Wenjiang, Chengdu, Sichuan, China 3Key Laboratory of Animal Disease and Human Health of Sichuan Province, Sichuan Agricultural University, Wenjiang, Chengdu, Sichuan, China Corresponding authors: A.C. Cheng / M.S. Wang E-mail: [email protected] / [email protected] Genet. Mol. Res. 14 (4): 13779-13790 (2015) Received April 23, 2015 Accepted July 30, 2015 Published October 28, 2015 DOI http://dx.doi.org/10.4238/2015.October.28.40 ABSTRACT. The US2 protein has been reported to contribute to duck enteritis virus (DEV) infection; however, its kinetics and localization during infection, and whether it is a component of virion, have not been previously reported. To elucidate the function of DEV US2, US2 was amplified by polymerase chain reaction (PCR) and inserted into pET-32a(+); this was expressed, the recombinant US2 protein was purified, and a polyclonal antibody generated. In addition, the kinetics and localization of the US2 gene and protein were determined by quantitative real-time fluorescent PCR, ganciclovir (GCV), and cycloheximide (CHX) treatment, western- blot, and indirect immunofluorescence assay. The packaging of US2 into DEV virions was revealed by a protease protection assay. -
Identi Cation of Campylobacter Jejuni and Chlamydia Psittaci from Cockatiel
Identication of Campylobacter Jejuni and Chlamydia Psittaci From cockatiel (Nymphicus Hollandicus) Using Metagenomics Si-Hyeon Kim Animal and Plant Quarantine Agency Yong-Kuk Kwon Animal and Plant Quarantine Agency Choi-Kyu Park Kyungpook National University Hye-Ryoung Kim ( [email protected] ) Animal and Plant Quarantine Agency Research Article Keywords: pet birds, cockatiel, metagenomics, chlamydiosis, campylobacteriosis, recombination, metaSPAdes Posted Date: June 1st, 2021 DOI: https://doi.org/10.21203/rs.3.rs-563212/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/16 Abstract Background In July 2015, the carcasses of 11 cockatiels were submitted for disease diagnosis to the Avian Disease Division of the Animal and Plant Quarantine Agency of Korea. The cockatiels, which appeared dehydrated and underweight, had exhibited severe diarrhea and 22% mortality over 2 weeks. Traditional diagnosis did not reveal the causes of these symptoms. Methods We conducted metagenomics analysis on intestines and livers from the dead cockatiels using Illumina high-throughput sequencing. To obtain more accurate and longer contigs, which are required for further genetic characterization, we compared the results of three de novo assembly tools (metaSPAdes, MEGAHIT, and IDBA-UD). Results Sequence reads of Campylobacter jejuni (C. jejuni) and Chlamydia psittaci (C. psittaci) were present in most of the cockatiel samples. Either of these bacteria could cause the reported symptoms in psittaciformes. metaSPAdes (ver.3.14.1) identied the 1152 bp aA gene of C. jejuni and the 1096 bp ompA gene of C. psittaci. Genetic analysis revealed that aA of C. jejuni was recombinant between C. -
Viral Infections of Nonhuman Primates
Laboratory Animal Science Vol 47, No 5 Copyright 1997 October 1997 by the American Association for Laboratory Animal Science Viral Infections of Nonhuman Primates Seymour S. Kalter,* Richard L. Heberling, Anthony W. Cooke, John D. Barry, Pei Y. Tian, and William J. Northam Abstract Approximately 53,000 serologic tests and viral isolation studies were performed on 1,700 nonhu- man primate specimens for evidence of past and/or current viral infection. Information, other than the re- quested test, generally was not provided with the specimen. This lack of information does not permit any attempt at interpretation of results. Requested testing included a large number of diverse viral agents in approximately 40 primate species. The resulting data are in keeping with those of previous studies and offer an insight into the needs of colony management, as well as some general information on the overall frequency of infection with the indicated viruses. Inasmuch as the results represent testing of single specimens, they are not to be construed as “diagnostic,” and simply indicate past infection as represented by the presence of antibody in the test animal. Viral isolation results are listed, and the number of positive results versus the number of animals tested emphasizes the limitations of the procedure. Investigations such as these continue to assist in the maintenance of healthy nonhuman primate colonies. This information also supports contin- ued use of nonhuman primates for research in human viral infections and may be helpful in terms of animal selection for use in xenotransplants. Continued study of nonhuman primates has clearly in- than the requested test(s), clinical or other information did dicated that these animals have a microflora not only of not accompany each specimen.